Bienvenu J - Search Results

1

Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment.

Bienvenu J, Chvetzoff R, Salles G, Balter C, Tilly H, Herbrecht R, Morel P, Lederlin P, Solal-Celigny P, Audhuy B, Christian B, Gabarre J, Casasnovas O, Marit G, Sebban C, Coiffier B; Groupe d'Etude des Lymphomes de l'Adulte. Bienvenu J, et al. Hematol J. 2001;2(6):378-84. doi: 10.1038/sj.thj.6200133. Hematol J. 2001. PMID: 11920277 Clinical Trial.

2

Tumor necrosis factor-alpha mRNA stability in human peripheral blood cells after lipopolysaccharide stimulation.

Baseggio L, Charlot C, Bienvenu J, Felman P, Salles G. Baseggio L, et al. Among authors: bienvenu j. Eur Cytokine Netw. 2002 Jan-Mar;13(1):92-8. Eur Cytokine Netw. 2002. PMID: 11956026 Free article.

3

Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma.

Lech-Maranda E, Bienvenu J, Michallet AS, Houot R, Robak T, Coiffier B, Salles G. Lech-Maranda E, et al. Among authors: bienvenu j. Eur Cytokine Netw. 2006 Mar;17(1):60-6. Eur Cytokine Netw. 2006. PMID: 16613764 Free article.

4

Factors that predict chemotherapy-induced myelosuppression in lymphoma patients: role of the tumor necrosis factor ligand-receptor system.

Voog E, Bienvenu J, Warzocha K, Moullet I, Dumontet C, Thieblemont C, Monneret G, Gutowski MC, Coiffier B, Salles G. Voog E, et al. Among authors: bienvenu j. J Clin Oncol. 2000 Jan;18(2):325-31. doi: 10.1200/JCO.2000.18.2.325. J Clin Oncol. 2000. PMID: 10637246

5

Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from non-Hodgkin's lymphoma patients.

Baseggio L, Bienvenu J, Charlot C, Picollet J, Felman P, Coiffier B, Salles G. Baseggio L, et al. Among authors: bienvenu j. Exp Hematol. 2001 Mar;29(3):330-8. doi: 10.1016/s0301-472x(00)00672-x. Exp Hematol. 2001. PMID: 11274761 Free article.

6

Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.

Warzocha K, Salles G, Bienvenu J, Bastion Y, Dumontet C, Renard N, Neidhardt-Berard EM, Coiffier B. Warzocha K, et al. Among authors: bienvenu j. J Clin Oncol. 1997 Feb;15(2):499-508. doi: 10.1200/JCO.1997.15.2.499. J Clin Oncol. 1997. PMID: 9053471

7

Prognostic significance of TNF alpha and its p55 soluble receptor in malignant lymphomas.

Warzocha K, Salles G, Bienvenu J, Barbier Y, Bastion Y, Doche C, Rieux C, Coiffier B. Warzocha K, et al. Among authors: bienvenu j. Leukemia. 1997 Apr;11 Suppl 3:441-3. Leukemia. 1997. PMID: 9209418

8

Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome.

Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, Rigal D, Coiffier B, Salles G. Warzocha K, et al. Among authors: bienvenu j. Blood. 1998 May 15;91(10):3574-81. Blood. 1998. PMID: 9572991 Free article.

9

Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.

Warzocha K, Bienvenu J, Ribeiro P, Moullet I, Dumontet C, Neidhardt-Berard EM, Coiffier B, Salles G. Warzocha K, et al. Among authors: bienvenu j. Br J Cancer. 1998 Jun;77(12):2357-62. doi: 10.1038/bjc.1998.391. Br J Cancer. 1998. PMID: 9649158 Free PMC article.

10

Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.

Warzocha K, Bienvenu J, Coiffier B, Salles G. Warzocha K, et al. Among authors: bienvenu j. Eur Cytokine Netw. 1995 Mar-Apr;6(2):83-96. Eur Cytokine Netw. 1995. PMID: 7578992 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters